Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +4.2K | +8.3% | $0.00 | 54.8K | May 2, 2024 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$138K | -1.92K | -3.5% | $72.03 | 52.9K | May 2, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -4.2K | -33.33% | $0.00 | 8.41K | May 2, 2024 | Common Stock | 4.2K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant. |